Dr. Anthony Fauci's National Institutes of Health (NIH) approved drug trial experiments on hundreds of AIDS orphans in New York City. Over 200 of the orphans died during or after the experiments, according to Liam Scheff, the investigative reporter who broke the story.
The Incarnation Children’s Center (ICC) "began testing drugs on its orphan population in 1992, the same year they became a subsidiary of Columbia University’s Pediatric AIDS Clinical Trial Unit, under Dr. Anne Gershon," Scheff noted. "In 2003, I went undercover inside the facility and saw the effects of the drugs on the children myself."
Scheff said his investigation found that the NIH and Columbia Presbyterian Hospital acted unethically.
The Associated Press reported in June 2005: “The government has concluded at least some AIDS drug experiments involving foster children violated federal rules designed to ensure vulnerable youths were protected from the risks of medical research.”
Fauci was the NIH AIDS Coordinator before being appointed as the first Director of the Office of AIDS research when the office was established in 1988. He served in that capacity until 1994. Fauci became director of the National Institute of Allergy and Infectious Diseases (NIAID) in 1984 and still holds that position.
Scheff reported several deaths in children at the ICC during the drug trials, adding that "although the mainstream denied that any deaths were due to drug toxicity, they admit that over 200 children died."
In 2005, the City of New York hired the VERA Institute to produce a final report on the drug trials. VERA was given no access to medical records for any of the children used in trials. Their report was published in 2008.
VERA reported that 25 children died during the drug studies, that an additional 55 children died following the studies (in foster care), and, according to Tim Ross, Director of the Child Welfare program at VERA (as of 2009), 29 percent of the remaining 417 children who were used in drug studies had died (out of a total 532 children that are admitted to have been used).
No payment or compensation was ever paid to any of the children used in the trials, or to their families, Scheff noted.
Many of the drugs (like AZT and its analogues) that were used in the experiments on the AIDS orphans in New York City had previously been approved for use in adults and "evidenced life-threatening and fatal toxicities," Scheff reported. "So why put a drug with severe recorded toxicities into a population of black and Hispanic orphans?"
Scheff noted: "Incarnation’s orphans live at the bottom of the American class system. Often the children of drug users, they were born into ill health and poverty. Additionally (and like all AIDS patients), these children were, because of their HIV status, written off as a loss by the medical authority, before they even got a chance to live."
Why wasn’t Fauci's NIH interested in competitive AIDS research?
"That’s the billion-dollar question," Scheff noted. "That is, if inexpensive micronutrients and competitive disease and treatment models prove more successful than the current research, it will represent a loss of billions for the AIDS drug and research industry."